Literature DB >> 28024277

QT prolongation caused by insulin-induced hypoglycaemia - An interventional study in 119 individuals.

Stella Kacheva1, Beate Karges2, Katrin Göller2, Nikolaus Marx3, Karl Mischke3, Wolfram Karges2.   

Abstract

AIMS: Hypoglycaemia is associated with increased risk of cardiovascular events and mortality in patients with diabetes, but the extent and mechanisms of this link are ill defined. We here prospectively studied cardiac repolarization abnormalities during insulin-induced hypoglycaemia in humans.
METHODS: 119 individuals (69 males, age 47.5±13.4years, range 18-82years) were assessed during hypoglycaemia after the injection of 0.1-0.25units/kg human insulin. Corrected QT intervals (QTc) and QT dispersion (QTd) were calculated from serially recorded twelve lead electrocardiograms, and plasma glucose and other endocrine markers were studied.
RESULTS: QTc increased from 415.1±21.9ms (mean±standard deviation) at baseline to 444.9±26.5ms during hypoglycaemia (plasma glucose nadir, 1.6±0.5mmol/L, p=0.001), accompanied by an increase of QTd from 45.0±22.7ms to 64.1±40.0ms (p<0.001). Hypoglycaemia-induced abnormal QTc prolongation (defined as ⩾460ms in females and ⩾450ms in males) occurred in 17% (9/54) of females and 26% (17/65) of males. 97 of 119 of individuals (82%) developed transient hypokalaemia (K+ ⩽3.6mmol/L), and plasma epinephrine increased from 220.4±169.5pmol/L at baseline to 2945.6±2421.4pmol/L during hypoglycaemia. Baseline QTc, but not age or gender, was a significant predictor of hypoglycaemia-induced QTc prolongation (p=0.001).
CONCLUSIONS: Insulin-induced hypoglycaemia frequently causes abnormal QT prolongation and is associated with hypokalaemia and sympathoadrenal activation, thereby increasing the potential risk for ventricular arrhythmias, particularly in individuals with pre-existing high normal QTc.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Epinephrine; Insulin-induced hypoglycaemia; QT dispersion; QTc prolongation

Mesh:

Substances:

Year:  2016        PMID: 28024277     DOI: 10.1016/j.diabres.2016.11.021

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  10 in total

1.  Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study.

Authors:  Francisco J Pasquel; Katerina Tsegka; Heqiong Wang; Saumeth Cardona; Rodolfo J Galindo; Maya Fayfman; Georgia Davis; Priyathama Vellanki; Alexandra Migdal; Unjali Gujral; K M Venkat Narayan; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2019-11-08       Impact factor: 19.112

2.  Autonomic cardiac regulation during spontaneous nocturnal hypoglycemia in children with type 1 diabetes.

Authors:  Sara Bachmann; Anne Auderset; Marie-Anne Burckhardt; Gabor Szinnai; Melanie Hess; Urs Zumsteg; Kris Denhaerynck; Birgit Donner
Journal:  Pediatr Diabetes       Date:  2021-09-17       Impact factor: 3.409

3.  Patients With Long-QT Syndrome Caused by Impaired hERG-Encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia.

Authors:  Louise Hyltén-Cavallius; Eva W Iepsen; Nicolai J Wewer Albrechtsen; Mathilde Svendstrup; Anniek F Lubberding; Bolette Hartmann; Thomas Jespersen; Allan Linneberg; Michael Christiansen; Henrik Vestergaard; Oluf Pedersen; Jens J Holst; Jørgen K Kanters; Torben Hansen; Signe S Torekov
Journal:  Circulation       Date:  2017-02-24       Impact factor: 29.690

4.  Usefulness of simultaneous and sequential monitoring of glucose level and electrocardiogram in monkeys treated with gatifloxacin under conscious and nonrestricted conditions.

Authors:  Yu Yoshimatsu; Tomomichi Ishizaka; Katsuyoshi Chiba; Kazuhiko Mori
Journal:  Exp Anim       Date:  2018-01-03

5.  Severity and multiplicity of microvascular complications are associated with QT interval prolongation in patients with type 2 diabetes.

Authors:  Shunsuke Kobayashi; Mototsugu Nagao; Akira Asai; Izumi Fukuda; Shinichi Oikawa; Hitoshi Sugihara
Journal:  J Diabetes Investig       Date:  2017-12-13       Impact factor: 4.232

6.  Multiple daily insulin injections ameliorate QT interval by lowering blood glucose levels in patients with type 2 diabetes.

Authors:  Shunsuke Kobayashi; Mototsugu Nagao; Izumi Fukuda; Shinichi Oikawa; Hitoshi Sugihara
Journal:  Ther Adv Endocrinol Metab       Date:  2021-04-22       Impact factor: 3.565

Review 7.  The Challenges of Predicting Drug-Induced QTc Prolongation in Humans.

Authors:  Jean-Pierre Valentin; Peter Hoffmann; Catherine Ortemann-Renon; John Koerner; Jennifer Pierson; Gary Gintant; James Willard; Christine Garnett; Matthew Skinner; Hugo M Vargas; Todd Wisialowski; Michael K Pugsley
Journal:  Toxicol Sci       Date:  2022-04-26       Impact factor: 4.109

Review 8.  Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis.

Authors:  Jianzhen Ye; Guangrui Deng; Feng Gao
Journal:  Drug Des Devel Ther       Date:  2018-04-19       Impact factor: 4.162

Review 9.  The somatostatin-secreting pancreatic δ-cell in health and disease.

Authors:  Patrik Rorsman; Mark O Huising
Journal:  Nat Rev Endocrinol       Date:  2018-07       Impact factor: 43.330

10.  In vivo cardiopulmonary impact of skeletal M3Dq DREADD expression: a pilot study.

Authors:  Sandra G Vincent; John T Fisher
Journal:  J Comp Physiol B       Date:  2021-07-16       Impact factor: 2.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.